Prepulse Inhibition (PPI) of Startle Reflex in Schizophrenia Patients Related to Type of Treatment and Illness Duration

NACompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

June 30, 2019

Study Completion Date

June 30, 2019

Conditions
Inhibition (Psychology)SchizophreniaMedication Adherence
Interventions
DEVICE

PPI monitoring device protocol

The investigators would use a monitoring device that would assess startle reflex reaction measured by blinking or the eye. Monitoring would be done with electrodes of EMG device that would be located on orbicularis oculi muscle and will monitor response.

OTHER

Questionnaires

"Group of patients diagnosed with schizophrenia would be interviewed using well validated questionnaires.~Questionnaires what would be used are:~1. GAF- Global assessment of functioning~2. PANSS- Positive and negative syndrome scale~3. SANS- Scale for the Assessment of Negative Symptoms~4. The Calgary Depression Scale for schizophrenia~5. Demographic Questionnaire~6. Hamilton Anxiety scale"

Trial Locations (1)

18101

Haemek Medical Center, Afula

All Listed Sponsors
lead

HaEmek Medical Center, Israel

OTHER

NCT02484521 - Prepulse Inhibition (PPI) of Startle Reflex in Schizophrenia Patients Related to Type of Treatment and Illness Duration | Biotech Hunter | Biotech Hunter